Observational studyCardiovascular diabetology2020

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study.

Chun-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.